CSBR
$6.20
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States.
Recent News
Champions Oncology (CSBR) Earnings Transcript
Robert Brainin: Good afternoon, and thank you for joining us for our third quarter fiscal 2026 earnings call. First, we delivered another quarter of strong operational performance, including record services revenue and our third consecutive quarter of positive adjusted EBITDA. Second, while quarterly revenue can fluctuate in our business, we remain on track for full year revenue growth and full year positive adjusted EBITDA while continuing to invest in both our data platform and our discovery therapeutics subsidiary.
Champions Oncology, Inc. Q3 2026 Earnings Call Summary
Moby summary of Champions Oncology, Inc.'s Q3 2026 earnings call
Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge
This SaaS provider enables brands to personalize customer engagement across digital channels using data-driven orchestration tools.
Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year
This marketing technology provider delivers data-driven automation and consumer insights to enterprise clients across multiple channels.
Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know
Kodiak AI, Inc. delivers AI-powered navigation software for trucking, defense, and industrial fleets using proprietary sensor technology.